Home » CEPHALON UP; GETS FDA APPROVABLE LETTER ON PAIN MED
CEPHALON UP; GETS FDA APPROVABLE LETTER ON PAIN MED
Cephalon Inc. (CEPH) shares jumped 10% Friday after the drug company said the government wanted more information before approving Cephalon's proposed new treatment for cancer pain. Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=984403&contentType=sentryarticle&channelID=29)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May